Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay
Franzblau S, Witzig R, McLaughlin J, et al. Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay. J Clin Microbiol 1998; 36: 362-366.
Drug susceptibility testing of Mycobacterium tuberculosis: A neglected problem at the turn of the century
Heifets L, Cangelosi G. Drug susceptibility testing of Mycobacterium tuberculosis: a neglected problem at the turn of the century. Int J Tuberc Lung Dis 1999; 3: 564-581.
Rapid alternative methods for detection of rifampicin resistance in Mycobacterium tuberculosis
Lemus D, Martin A, Montoso E, Portaels F, Palomino J C. Rapid alternative methods for detection of rifampicin resistance in Mycobacterium tuberculosis. J Antimicrob Chemother 2004; 54: 130-133.
Resazurin microtiter assay plate: Simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis
Palomino J C, Martin A, Camacho M, Guerra H, Swings J, Portaels F. Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2002; 46: 2720-2722.
Kent P, Kubica G, eds, Atlanta, GA, USA: US Department of Health and Human Services
Kent P, Kubica G, eds. Public health mycobacteriology: a guide for the level III laboratory. Atlanta, GA, USA: US Department of Health and Human Services, 1985.
Advances in techniques of testing mycobacterial drug sensitivity and the use of sensitivity test in tuberculosis control programmes
Cannetti G, Fox W, Khomenko A, et al. Advances in techniques of testing mycobacterial drug sensitivity and the use of sensitivity test in tuberculosis control programmes. Bull World Health Organ 1969; 41: 21-43.
Global Tuberculosis Programme. Annex 2: Individual country profiles
World Health Organization, Geneva, Switzerland: WHO
World Health Organization, Global Tuberculosis Programme. Annex 2: individual country profiles. In: Anti-tuberculosis drug resistance in the world, The WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance 1994-1997. Geneva, Switzerland: WHO, 1997: p 153.